What is an appropriate control group to identify risk factors for Clostridium difficile-associated diarrhoea? [9]

Journal of Antimicrobial Chemotherapy

Volumn 48, Issue 5, 2001, Pages 747-748

  Guyot, Andrea ^a   Barrett, Steve P ^b  

^a WEST MIDDLESEX UNIVERSITY HOSPITAL   (United Kingdom)

^b CHARING CROSS HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT; CEFUROXIME; CEPHALOSPORIN; CLARITHROMYCIN; MACROLIDE;

ADULT; AGED; ANTIBIOTIC RESISTANCE; BACTERIAL OVERGROWTH; CLOSTRIDIUM DIFFICILE; CONTROLLED STUDY; DIARRHEA; DISEASE ASSOCIATION; HOSPITAL ADMISSION; HOSPITAL PATIENT; HOSPITALIZATION; HUMAN; LENGTH OF STAY; LETTER; MONOTHERAPY; PATHOPHYSIOLOGY; PNEUMONIA; QUESTIONNAIRE; RESPIRATORY TRACT INFECTION; RISK FACTOR; STRAIN DIFFERENCE; SYMPTOMATOLOGY; VIRULENCE;

ANTI-BACTERIAL AGENTS; CLARITHROMYCIN; CLOSTRIDIUM DIFFICILE; DIARRHEA; ENTEROCOLITIS, PSEUDOMEMBRANOUS; HUMANS; RESEARCH DESIGN; RISK FACTORS;

EID: 0035179031     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (5)

1. Clarithromycin appears to be linked with Clostridium difficile-associated diarrhoea in the elderly
2. Clarithromycin and risk of Clostridium difficile-associated diarrhoea
3. Epidemic Clostridium difficile-associated diarrhoea: Role of second and third generation cephalosporins
4. Health care resource utilization and antimicrobial use in elderly patients with community-acquired lower respiratory tract infection who develop Clostridium difficile-associated diarrhoea
5. SHEA position paper: Clostridium difficile-associated diarrhoea and colitis